Dermatol. praxi. 2018;12(2):60-63 | DOI: 10.36290/der.2018.010

Erythroderma

doc. MUDr. Ivana Kuklová, CSc.
Dermatovenerologická klinika 1. LF UK a VFN, Praha

Erythroderma also sometimes called exfoliative dermatitis, is a severe and potentially life-threatening condition that presentswith diffuse erythema and scaling involving most of the skin surface area (≥90 percent, in the most common definition). Erythrodermais a rare condition. The annual incidence has been estimated to be approximately 1 per 100,000 in the adult population.The most common cause of erythroderma is the exacerbation of a preexisting inflammatory dermatosis, most often psoriasis oratopic dermatitis. A hypersensitivity drug reaction is the second most frequent cause of erythroderma (approximately 20 percentof cases) followed by uncommon causes (T-cell lymphoma and other hematologic and systemic malignancies, immunobullousdiseases, connective tissue diseases, and infections). In approximately 25 percent of cases of erythroderma, no underlying causeis identified and erythroderma is classified as idiopathic.

Keywords: erythroderma, pathogenesis, classification, treatment

Published: July 1, 2018  Show citation

ACS AIP APA ASA Harvard Chicago Chicago Notes IEEE ISO690 MLA NLM Turabian Vancouver
Kuklová I. Erythroderma. Dermatol. praxi. 2018;12(2):60-63. doi: 10.36290/der.2018.010.
Download citation

References

  1. Sigurdsson V, Steegmans PH, van Vloten WA. The incidence of erythroderma: a survey among all dermatologists in The Netherlands. J Am Acad Dermatol 2001; 45: 675. Go to original source... Go to PubMed...
  2. Li J, Zheng HY. Erythroderma: a clinical and prognostic study. Dermatology 2012; 225: 154. Go to original source... Go to PubMed...
  3. Pal S, Haroon TS. Erythroderma: a clinico-etiologic study of 90 cases. Int J Dermatol 1998; 37: 104. Go to original source... Go to PubMed...
  4. Akhyani M, Ghodsi ZS, Toosi S, Dabbaghian H. Erythroderma: a clinical study of 97 cases. BMC Dermatol 2005; 5: 5. Go to original source... Go to PubMed...
  5. Rym BM, Mourad M, Bechir Z, et al. Erythroderma in adults: a report of 80 cases. Int J Dermatol 2005; 44: 731. Go to original source... Go to PubMed...
  6. Sigurdsson V, Toonstra J, Hezemans-Boer M, van Vloten WA. Erythroderma. A clinical and follow-up study of 102 patients, with special emphasis on survival. J Am Acad Dermatol 1996; 35: 53. Go to original source... Go to PubMed...
  7. Rothe MJ, Bernstein ML, Grant-Kels JM. Life-threatening erythroderma: diagnosing and treating the "red man". Clin Dermatol 2005; 23: 206. Go to original source... Go to PubMed...
  8. Sheen YS, Chu CY, Wang SH, Tsai TF. Dapsone hypersensitivity syndrome in non-leprosy patients: a retrospective study of its incidence in a tertiary referral center in Taiwan. J Dermatolog Treat 2009; 20: 340 Go to original source... Go to PubMed...
  9. Groves RW, Kapahi P, Barker JN, et al. Detection of circulating adhesion molecules in erythrodermic skin disease. J Am Acad Dermatol 1995; 32: 32. Go to original source... Go to PubMed...
  10. Sigurdsson V, de Vries IJ, Toonstra J, et al. Expression of VCAM-1, ICAM-1, E-selectin, and P-selectin on endothelium in situ in patients with erythroderma, mycosis fungoides and atopic dermatitis. J Cutan Pathol 2000; 27: 436 Go to original source... Go to PubMed...
  11. Kanthraj GR, Srinivas CR, Devi PU, et al. Quantitative estimation and recommendations for supplementation of protein lost through scaling in exfoliative dermatitis. Int J Dermatol 1999; 38: 91. Go to original source... Go to PubMed...
  12. Ram-Wolff C, Martin-Garcia N, Bensussan A, et al. Histopathologic diagnosis of lymphomatous versus inflammatory erythroderma: a morphologic and phenotypic study on 47 skin biopsies. Am J Dermatopathol 2010; 32: 755. Go to original source... Go to PubMed...
  13. Zip C, Murray S, Walsh NM. The specificity of histopathology in erythroderma. J Cutan Pathol 1993; 20: 393. Go to original source... Go to PubMed...
  14. Nagler AR, Samimi S, Schaffer A, et al. Peripheral blood findings in erythrodermic patients: importance for the differential diagnosis of Sézary syndrome. J Am Acad Dermatol 2012; 66: 503. Go to original source... Go to PubMed...
  15. Egeberg A, Thyssen JP, Gislason GH, Skov L. Prognosis after Hospitalization for Erythroderma. Acta Derm Venereol 2016; 96: 959. Go to original source... Go to PubMed...




Dermatology for Practice

Madam, Sir,
please be aware that the website on which you intend to enter, not the general public because it contains technical information about medicines, including advertisements relating to medicinal products. This information and communication professionals are solely under §2 of the Act n.40/1995 Coll. Is active persons authorized to prescribe or supply (hereinafter expert).
Take note that if you are not an expert, you run the risk of danger to their health or the health of other persons, if you the obtained information improperly understood or interpreted, and especially advertising which may be part of this site, or whether you used it for self-diagnosis or medical treatment, whether in relation to each other in person or in relation to others.

I declare:

  1. that I have met the above instruction
  2. I'm an expert within the meaning of the Act n.40/1995 Coll. the regulation of advertising, as amended, and I am aware of the risks that would be a person other than the expert input to these sites exhibited


No

Yes

If your statement is not true, please be aware
that brings the risk of danger to their health or the health of others.